Advertisement

Topics

Reasons for TKI Discontinuation ID'd in Chronic Myeloid Leukemia

08:00 EDT 16 Apr 2019 | Drugs.com

TUESDAY, April 16, 2019 -- For patients with chronic myeloid leukemia (CML), tyrosine kinase inhibitor (TKI) therapy can be safely discontinued and yields high rates of treatment-free remission (TFR), according to a study published online March 16...

Original Article: Reasons for TKI Discontinuation ID'd in Chronic Myeloid Leukemia

NEXT ARTICLE

More From BioPortfolio on "Reasons for TKI Discontinuation ID'd in Chronic Myeloid Leukemia"

Advertisement
Quick Search
Advertisement
Advertisement